Home > News > Nanosphere’s gene analyzer soars through first testing round
April 22nd, 2004
Nanosphere’s gene analyzer soars through first testing round
Abstract:
The early reviews on Nanosphere, Inc.'s nanoparticle-based gene detection technology are beginning to come in. And it looks like the technology could be a hit with the lucrative clinical lab market, according to its first group of testers. The Northbrook, Ill.-company launched its Verigene tabletop analyzer for the research market last June. The analyzer is based on core technology that involves coating gold nanoparticles with strings of nucleotides that complement a given genetic target.
Source:
SmallTimes
Related News Press |
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Profiles
Russia’s Nano-enabled Products Market to Witness Massive Growth February 8th, 2011
Adept Technology Announces Orders for Over $600K from Chinese Partner January 18th, 2011
Nanostart-held ItN Nanovation Receives Major Follow-on Order in Saudi Arabia November 29th, 2010
Homegrown Companies Developing Batteries for Clean Energy Storage November 2nd, 2010
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||